Lipid Disorders and Metabolic-Associated Fatty Liver Disease
Endocrinology and Metabolism Clinics of North America · 2023-09 · 52 (3) · 445-457
DOI: 10.1016/j.ecl.2023.01.003 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Endocrinology and Metabolism Clinics of North America, 2023-09. Verfasst von Shima Dowla Anwar und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Boston Children Hospital, Harvard Medical School, Boston, MA, USA. Hauptthemen laut MEDLINE: Non-alcoholic Fatty Liver Disease. Die Arbeit wurde bisher 71-mal zitiert (Crossref) und nennt 50 Literaturangaben.
Abstract (Originalsprache)
Dyslipidemia has been linked metabolic-associated fatty liver disease (MAFLD). Several genes and transcription factors involved in lipid metabolism can increase susceptibility to MAFLD. Multiple parallel 'hits' have been proposed for developing hepatic steatosis, NASH, and MAFLD, including insulin resistance and subsequent free fatty acid excess, de novo lipogenesis, and excessive hepatic triglyceride and cholesterol deposition in the liver. This lead to defective beta-oxidation in the mitochondria and VLDL export and increased inflammation. Given the significant cardiovascular risk, dyslipidemia associated with MAFLD should be managed by lifestyle changes and lipid-lowering agents such as statins, fenofibrate, and omega-3 fatty acids, with judicious use of insulin-sensitizing agents, and adequate control of dysglycemia.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, Boston Children Hospital, Harvard Medical School, Boston, MA, USA.
- University of Alabama at Birmingham, 1601, 4th Avenue South, CPP M 30, Birmingham, AL 35233, USA.
- University of Alabama at Birmingham, 1601, 4th Avenue South, CPP M 30, Birmingham, AL 35233, USA. Electronic address: AAshraf@uabmc.edu.
Zitieren
APA
Anwar, S. D., Foster, C., & Ashraf, A. (2023). Lipid Disorders and Metabolic-Associated Fatty Liver Disease. Endocrinology and Metabolism Clinics of North America, 52(3), 445-457. https://doi.org/10.1016/j.ecl.2023.01.003
Vancouver
Anwar SD, Foster C, Ashraf A. Lipid Disorders and Metabolic-Associated Fatty Liver Disease. Endocrinology and Metabolism Clinics of North America. 2023;52(3):445-457. doi:10.1016/j.ecl.2023.01.003
BibTeX
@article{Anwar2023,
author = {Anwar, Shima Dowla and Foster, Christy and Ashraf, Ambika},
title = {Lipid Disorders and Metabolic-Associated Fatty Liver Disease},
journal = {Endocrinology and Metabolism Clinics of North America},
year = {2023},
volume = {52},
number = {3},
pages = {445--457},
doi = {10.1016/j.ecl.2023.01.003}
}
EUVIMED